|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Eskalith (lithium carbonate) Capsules and Eskalith CR (lithium carbonate) Controlled Release Tablets, SmithKline Beecham NDA 16-860/S-073, 17-971/S-019 & 18-152/S-017 Lithium Carbonate Capsules & Syrup, Roxane, NDA 17-812/S23 & 18-421/ S21 1/31/03 2/12/03
Lithium Carbonate Capsules, USP, 150, 300 and 600 mg, Roxane, NDA 17-812/SCP-021 6/14/01 11/25/02
Lithium Carbonate Capsules & Lithium Citrate Syrup, Roxane, NDA 17-812/S-011, S-013, S-014, S-016 & S-017 & 18-421/S-011, S-013, S-014, S-015, S-016 11/26/01 2/12/02
Lithium Carbonate Capsules & Controlled Release Tablets, SmithKline Beecham NDA 16-860/S59, S65, S67, S68, S69, S72 & 18-152/S3, S8, S10, S12, S13, S16 5/8/02 5/16/02
Lithium Carbonate Tablets ER, 450 mg, Barr ANDA 76-366 8/21/03
Lithium Carbonate Capsules USP, 150 mg, West-ward Pharmaceutical Corp. ANDA 76-243/S1 2/24/03
Lithium Carbonate Capsules USP, 300 mg, West-ward Pharmaceutical Corp. ANDA 76-243 6/27/02
Lithium Carbonate Capsules USP, 300 mg, Able, ANDA 76-121 9/27/01 4/16/03
Lithium Carbonate Extended-Release Tablets USP, 300 mg, Able ANDA 76-382 4/21/03
Lithium Carbonate Extended-Release Tablets USP, 300 mg, Barr, ANDA 76-170 LITHIUM CARBONATE Capsule; 300MG LITHIUM CARBONATE Able 016860 LITHIUM CARBONATE Capsule; 300MG ESKALITH GLAXOSMITHKLINE
017812 LITHIUM CARBONATE Capsule; 150MG LITHIUM CARBONATE Roxane
017812 LITHIUM CARBONATE Capsule; 300MG LITHIUM CARBONATE Roxane
017812 LITHIUM CARBONATE Capsule; 600MG LITHIUM CARBONATE Roxane
076243 LITHIUM CARBONATE Capsule; 150MG LITHIUM CARBONATE West Ward
076243 LITHIUM CARBONATE Capsule; 300MG LITHIUM CARBONATE West Ward
076382 LITHIUM CARBONATE Tablet, Extended Release; 300MG LITHIUM CARBONATE Able 076170 LITHIUM CARBONATE Tablet, Extended Release; 300MG LITHIUM CARBONATE Barr 076366 LITHIUM CARBONATE Tablet, Extended Release; 450MG LITHIUM CARBONATE Barr 018152 LITHIUM CARBONATE Tablet, Extended Release; 450MG ESKALITH CR GLAXOSMITHKLINE
018027 LITHIUM CARBONATE Tablet, Extended Release; 300MG LITHOBID SOLVAY
076490 LITHIUM CARBONATE Tablet, Extended Release; 450MG LITHIUM CARBONATE West Ward
016834 LITHIUM CARBONATE Tablet; 300MG LITHIUM CARBONATE PFIZER
018558 LITHIUM CARBONATE Tablet; 300MG LITHIUM CARBONATE Roxane
070755 LITHIUM CITRATE Syrup; 300MG CARBONATE/5ML LITHIUM CITRATE Morton Grove
018421 LITHIUM CITRATE Syrup; 300MG CARBONATE/5ML LITHIUM CITRATE Roxane
Eskalith (lithium carbonate) Capsules, Tablets & CR Tablets, GlaxoSmithKline
Lithium Carbonate Capsules, Able Laboratories, Inc. Approval | Lithium Carbonate Extended-Release Tablets, Roxane Labs, Approval | Lithium Carbonate Capsules, Apotex, Approval | Lithobid (Lithium Carbonate) Slow-Release Tablets, JDS Pharma, Labeling Revision | Lithobid (lithium carbonate, USP) Extended-Release Tablets, JDS Pharmaceuticals, Labeling Revision
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|